This is unpublished

Christine M.
Johnston
MD, MPH

Christine Johnston

(206) 520-4340

325 9th Ave                      Box 359928            Seattle, WA 98104

Faculty
Infectious Diseases
Pinned
Academic
Associate Professor Department of Medicine, Division of Allergy and Infectious Diseases
Professional
Associate Director, Infectious Diseases Fellowship Training Program
Associate Medical Director, UW Virology Research Clinic
Research Affiliate, Fred Hutchinson Cancer Research Center

Related Links

Bio

Dr. Johnston is a physician-scientist who performs clinical studies of genital herpes simplex virus type 2 (HSV-2) infection, focused on characterizing spatial localization of subclinical genital shedding and host-virus interactions. In addition, research interests include studies of existing and novel antiviral agents to suppress HSV-2 genital shedding, and the interactions between HSV-2 and coinfections in the female genital tract, specifically HIV-1 and bacterial vaginosis.

Education & Training

MD, University of Minnesota Medical School, Minneapolis MN (2001)

MPH, School of Public Health and Community Medicine, University of Washington, Seattle WA (2007)

Residency, Department of Medicine, University of Washington, Seattle WA (2001-2004)

Fellowship in Infectious Diseases, Department of Medicine, University of Washington, Seattle WA (2004-2007)

Honors

Alfred D Milburn Scholarship, University of Minnesota (1998)

Neal and Sarah Gault International Study Award, University of Minnesota (2001)

Joel E Meyers Infectious Disease Scholarship Award, Fred Hutchinson Cancer Research Center (2004)

Publications

PubMed

Johnston C, Zhu J, Jing L, Laing KJ, McClurkan C, Klock A, Diem K, Jin L, Stanaway J, Tronstein E, Kwok W, Huang M, Selke S, Fong Y, Magaret A, Koelle DM, Wald A, Corey L. Virologic and immunologic evidence of multifocal genital herpes simplex virus type 2 infection. J Virol. 2014; 88(9):4921-31.
• Journal of Virology Abstract

Johnston C, Koelle DM, Wald A. Current status and prospect for development of an HSV vaccine. Vaccine. 2014; 32(14):1553-60.
• PubMed Abstract

Johnston C, Saracino M, Kuntz S, et al. Standard-dose and high-dose daily antiviral therapy for short episodes of genital HSV-2 reactivation: three randomised, open-label, cross-over trials. Lancet. 2012; 179(9816):641-7.
• PubMed Abstract

Johnston C, Koelle DM, Wald A. HSV-2: in pursuit of a vaccine. J Clin Invest. 2011; 121(12),4600-9.
• PubMed Abstract

Tronstein E, Johnston C, Huang M, et al. Genital shedding of herpes simplex virus among symptomatic and asymptomatic persons with HSV-2 infection. JAMA. 2011; 305(14):1441-9.
• PubMed Abstract

Johnston C, Orem J, Okuku F, Kalinaki M, Saracino M, Mbidde-Katongole E. Impact of HIV infection and Kaposi Sarcoma on human herpesvirus-8 mucosal and replication and dissemination in Uganda. PLoS ONE. 2009; 4(1):e4222. 
• PubMed Abstract

Johnston C, Magaret A, Selke S, Remington M, Corey L, Wald A. Herpes simplex virus viremia during primary genital infection. J Infect Dis. 2008; 198(1):31-4. 
• PubMed Abstract